Brooks Laboratories Ltd share price logo

Brooks Laboratories Ltd Share Price

NSE: BROOKS

BSE: 533543

Small Cap

Healthcare Sector

₹106.95

-2.87

(-2.61%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Brooks Laboratories Ltd Stock Performance

as on November 14, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹106
    ₹112.33
    downward going graph

    0.89%

    Downside

    5.03%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹95.55
    ₹198.86
    downward going graph

    10.66%

    Downside

    85.94%

    Upside

    downward going graph

Brooks Laboratories Ltd share price movements today

Previous Close
₹109.82
Open
₹111.00
Volume
47.42K
Upper Circuit
₹120.80
Lower Circuit
₹98.83
Day's Low - High
₹106 - ₹112.33
52 Week Low - High
₹95.55 - ₹198.86

Brooks Laboratories Ltd Historical Returns

1 Month Return
-13.18 %
3 Month Return
-28.76 %
1 Year Return
-22.9 %
3 Year Return
-1.43 %
5 Year Return
+ 66.07 %

Brooks Laboratories Ltd Fundamentals

as on November 14, 2025 at 4:01 pm IST

Market Cap

₹315.05 Cr

Return on Equity (ROE)

2.43

PE Ratio (TTM)

29.14

Return on capital employed (ROCE)

3.19

Industry PE ratio

42.22

Beta (LTM)

0.94

P/B Ratio

2.76

Dividend Yield

0

PEG Ratio

2.56

Quarterly Earnings Growth YOY

-301.52

EPS (TTM)

-3.38

Sector

Pharmaceuticals

Book Value

33.3

Technical Analysis

Bearish

View Technical Analysis

Brooks Laboratories Ltd Stock Valuation

as on November 14, 2025 at 4:01 pm IST

Brooks Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-293.64x)

July 22, 2025

Today (29.14x)

November 14, 2025

Industry (42.22x)

November 14, 2025

Highest (36.88x)

October 3, 2025

LowHigh

Today’s Price to Earnings Ratio: 29.14x

Brooks Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Brooks Laboratories Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Brooks Laboratories Ltd image
Brooks Laboratories Ltd
NA315.0513.21%0.54-1082
Samrat Pharmachem Ltd image
Samrat Pharmachem Ltd
NA84.2128.52%0.007285
Themis Medicare Ltd image
Themis Medicare Ltd
NA1,076.5047.67%0.5929405
Venmax Drugs & Pharmaceuticals Ltd image
Venmax Drugs & Pharmaceuticals Ltd
NA15.1968.12%0.00-1NA
Granules India Ltd image
Granules India Ltd
BUY13,303.108.38%0.645014,481
See all

Brooks Laboratories Ltd Stock’s Investor Sentiment and Interest

Search interest for Brooks Laboratories Ltd Stock has increased by 128% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:128% versus previous 30 day period

Brooks Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
15.3
12.61
15.7
24.32
21.75
17.72
17.93
20.79
20.52
23.32
25.51
23.45
Other Income
0.45
0.03
0.05
0.09
0.16
0.65
0.07
0.2
0.03
0.62
7.15
6.13
Total Income
15.76
12.64
15.76
24.41
21.9
18.38
18
20.99
20.54
23.94
32.66
29.58
Expenses
23.86
16.31
19.62
25.42
25.11
27.25
19.85
24.2
22.01
24.57
22.39
20.93
Operating Profit
-8.56
-3.7
-3.92
-1.1
-3.36
-9.53
-1.92
-3.41
-1.49
-1.25
3.12
2.52
Operating Profit Margin %
-55.95%
-29.34%
-24.97%
-4.52%
-15.45%
-53.78%
-10.71%
-16.4%
-7.26%
-5.36%
12.23%
10.75%
Profit Before Interest, Tax and Depreciation
-8.1
-3.67
-3.86
-1.01
-3.21
-8.88
-1.85
-3.21
-1.46
-0.63
10.28
8.65
Interest
0.75
0.18
0.17
0.19
0.21
0.27
0.16
0.32
0.28
0.26
0.3
0.28
Depreciation
2.33
0.44
0.44
0.44
0.43
0.46
0.4
0.43
0.38
0.39
0.39
0.39
Profit Before Tax
-11.18
-4.29
-4.47
-1.64
-3.85
-9.61
-2.41
-3.96
-2.12
-1.28
9.59
7.98
Tax Paid
-1.7
-
-
-
0.03
-
-
-
-
0.18
-
-
Profit After Tax
-9.48
-4.29
-4.47
-1.64
-3.88
-9.61
-2.41
-3.96
-2.13
-1.46
9.58
7.98
Total Net profit including share of profit / Loss from associate company
-9.48
-4.29
-4.47
-1.64
-3.88
-9.61
-2.41
-3.96
-2.13
-1.46
9.58
7.98
EPS
-2.03
-1.75
-1.81
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71
Actual EPS
-2.03
-1.75
-1.81
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71
Adjusted EPS
-2.01
-1.73
-1.79
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71
Diluted EPS
-2.03
-1.75
-1.81
-0.6
-1.51
-3.77
-0.94
-1.51
-1.75
-0.54
3.25
2.71

Brooks Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
77.25
91.08
63.2
79.49
82.56
Other Income
0.74
0.91
0.57
0.92
0.88
Total Income
77.98
91.99
63.77
80.4
83.44
Expenses
76.73
105.44
92.93
97.35
90.6
Operating Profit
0.52
-14.36
-29.73
-17.86
-8.04
Operating Profit Margin %
0.67%
-15.77%
-47.04%
-22.47%
-9.74%
Profit Before Interest, Tax and Depreciation
1.25
-13.45
-29.16
-16.95
-7.16
Interest
3.1
3.1
2.18
0.84
1.03
Depreciation
7.14
7.35
7.03
1.77
1.6
Profit Before Tax
-8.99
-23.9
-38.37
-19.56
-9.79
Tax Paid
10.38
-4.59
-7.32
0.03
0.18
Profit After Tax
-19.38
-19.31
-31.05
-19.59
-9.97
Total Net profit including share of profit / Loss from associate company
-19.38
-19.31
-31.05
-19.59
-9.97
EPS
-6.31
-7.82
-12.57
-7.67
-3.72
Actual EPS
-6.31
-7.82
-12.57
-7.67
-3.72
Adjusted EPS
-6.25
-7.74
-12.45
-7.67
-3.72
Diluted EPS
-6.31
-7.82
-12.57
-7.67
-3.72

Brooks Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
4.46
-37.44
-14.49
-9.8
2.63
Cash Flow from Investing Activities
-5.13
-20.52
0.49
0.18
-45.14
Cash Flow from Financing Activities
1.15
64.07
11.41
9.72
42.42
Net Cash Flow
0.49
1.72
-2.58
0.1
-0.08

Brooks Laboratories Ltd Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Jan 2025
Mar 2025
Jun 2025
Sep 2025
Promoters
66.41%
66.41%
66.41%
63.59%
63.59%
63.59%
63.59%
63.59%
63.59%
59.06%
52.62%
52.62%
52.62%
52.62%
DII
0.06%
0.06%
0%
1.25%
2.46%
3.86%
3.86%
3.86%
3.86%
3.86%
9.9%
10.38%
10.38%
10.38%
FII
0%
0%
0%
0%
0%
0%
0%
0%
0.02%
0.01%
0%
0.05%
0%
0.01%
Public
33.52%
33.52%
33.59%
35.16%
33.94%
32.55%
32.55%
32.55%
32.53%
37.08%
37.48%
36.95%
37%
37%
Total Outstanding Shares
2,47,02,812
2,47,02,812
2,47,02,812
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,62,46,738
2,94,57,248
2,94,57,248
2,94,57,248
2,94,57,248
Total Shareholders
10,410
10,709
11,216
11,141
10,686
10,028
11,432
11,543
11,282
10,521
10,374
10,537
10,317
10,078

Mutual Funds that own Brooks Laboratories Ltd Stock

Check out the Mutual Funds with significant holdings in Brooks Laboratories Ltd.

Funds
Holdings
Shares Held
Quant Business Cycle Fund Direct Growth
Quant Business Cycle Fund Direct Growth
2.8%
2916111

Brooks Laboratories Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Brooks Laboratories Ltd.

  • Brooks Laboratories Ltd Earnings Results

    Brooks Laboratories Ltd’s net profit jumped 301.52% since last year same period to ₹7.98Cr in the Q2 2025-2026. On a quarterly growth basis, Brooks Laboratories Ltd has generated -16.7% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Brooks Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.00% to 0.01% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.5% return, outperforming this stock by 133.0%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.62% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 37.00% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.4% return, outperforming this stock by 46.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 9.58 Cr → 7.98 Cr (in ₹), with an average decrease of 16.7% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, BROOKS stock has moved down by -13.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 32.66 Cr → 29.58 Cr (in ₹), with an average decrease of 9.4% per quarter

About Brooks Laboratories Ltd

Brooks Laboratories Ltd is an esteemed pharmaceutical manufacturing company that has established plants in Baddi, Himachal Pradesh and Vadodara, Gujarat. The Vadodara facility was approved by the European Medicine Agency, and the company’s product portfolio consists of 28 injectables, 19 tablets and 2 dry syrups that are catered to the critical care segment. They are sourced from suppliers like Rajasthan Antibiotics Ltd, Aurobindo Pharma Ltd, DSM Anti Infectives Ltd and Qilu Pharmaceutical Company Ltd, and served to clients like Zydus Cadila, Aristo Pharmaceuticals Pvt Ltd, FDC Ltd, Nectar Lifesciences Ltd and Sanat Products Ltd.

Brooks Laboratories Ltd was established in January 2002 and it started operations and commercial production in May and June 2006 respectively. It obtained an ISO 9001:2008 Certificate in August 2007 and an Import License from Drugs Controller General of India in October 2006. On August 2011, they raised Rs. 63 crore through IPO and their shares officially listed on stock exchanges in September 2011.

Their current manufacturing facility at Baddi is 100% operational, with world class dedicated carbapenem facility in Vadodara Plant which commenced activity on 7 March 2017. Baddi facility was upgraded in June 2017 for 3 months, and production in injectable line resumed from September onwards. Finally, production commenced in August 2017 in the renovated building and was almost double than the previous line.

Revenue: ₹23.45Cr as on September 2025 (Q2 FY26)
Net Profit: ₹7.98Cr as on September 2025 (Q2 FY26)
Listing date: 05 Sep, 2011
OrganisationBrooks Laboratories Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Brooks Laboratories Ltd share price today?

Brooks Laboratories Ltd share price today stands at ₹106.95 as on at the close of the market. Brooks Laboratories Ltd share today touched a day high of ₹112.33 and a low of ₹106.

What is the 52 week high and 52 week low range for Brooks Laboratories Ltd share?

Brooks Laboratories Ltd touched a 52 week high of ₹198.86 and a 52 week low of ₹95.55. Brooks Laboratories Ltd share price today i.e. is closed at ₹106.95, which is -46.22% down from its 52 week high and 11.93% up from its 52 week low.

What is Brooks Laboratories Ltd's market capitalisation today?

Brooks Laboratories Ltd market capitalisation is ₹315.05 Cr as on .

How to buy Brooks Laboratories Ltd shares?

To buy Brooks Laboratories Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for BROOKS or Brooks Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Brooks Laboratories Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Brooks Laboratories Ltd trading volume today?

Brooks Laboratories Ltd trading volume is 47.42K as on . This means that 47.42K shares of Brooks Laboratories Ltd were bought and sold on the stock market during today's trading session.